Journal profile · Medicine-Biochemistry (medical)
Journal of Circulating Biomarkers
ISSN 1849-4544 · SAGE · Italy
Journal of Circulating Biomarkers: fully open access; APC charged, amount not published; median 134 days to acceptance (18 articles, last 24 months); 9 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Journal of Circulating Biomarkers is published by SAGE. By OpenAlex counts of its recent articles, its largest topics are Extracellular vesicles in disease, Cancer Genomics and Diagnostics and Cellular transport and secretion, together about 42% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Circulating Biomarkers (JCB) is an international, peer-reviewed, open access, scientific, online only journal, published continually. It focuses on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications, circulation protein and lipid markers, CTC, cfDNA and extracellular vesicle, within the following sections.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Biochemistry (medical)
Editor-in-chief Luiz ZerbiniPublisher website
Editorial board by country: none in mainland China; most named Italy 2, United States 1, South Africa 1, United Arab Emirates 1 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology23.9%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology12.1%
- Cellular transport and secretionBiochemistry, Genetics and Molecular Biology6.1%
- Nanoparticle-Based Drug DeliveryMaterials Science4.9%
- Cancer Cells and MetastasisMedicine4.6%
- Microfluidic and Bio-sensing TechnologiesEngineering4.6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology3.8%
- Heart Failure Treatment and ManagementMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Biochemistry (medical) | Q2 | 26/78 | 67th |
| Clinical Biochemistry | Q2 | 47/124 | 62nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 5.6LetPub ·
- SJR 2026-06
- 0.66LetPub ·
- SNIP 2026-06
- 0.97LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 51OpenAlex ·
- 2-year mean citedness
- 1.56OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 177 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 11 | 11 | 171 |
| 2025 | 9 | 9 | 238 |
| 2024 | 7 | 7 | 256 |
| 2023 | 5 | 5 | 287 |
| 2022 | 8 | 8 | 291 |
| 2021 | 5 | 5 | 294 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
134 daysMedian, submission to acceptance · P25–P75 116 days – 178 days
- Acceptance to online
- median 24 days (18 articles)
- Submission to online
- median 170 days
- Sample
- 18 articles with submission and acceptance dates (0 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 1,500 | No | CC BY-NC | |
| OpenAlex | EUR 1,500 | — | — | |
| LetPub | EUR 1,500 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- AMA
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAuthorship, Open access, Peer review
- Authorship
Original work only, not under consideration elsewhere Model summary
Manuscripts submitted to Journal of Circulating Biomarkers must be an original contribution not previously published in any language or country (except as an abstract or preliminary report) and must not be under consideration for publication elsewhere.
Source ↗Publisher website ·- Open access
Open access under CC-BY-NC 4.0 license Model summary
Authors contributing to Journal of Circulating Biomarkers agree to publish their articles under the CC-BY-NC 4.0 license, which allows third parties to re-use the work without permission as long as the work is properly referenced and the use is non-commercial.
Source ↗Publisher website ·- Peer review
EQUATOR Network reporting guidelines required Model summary
Journal of Circulating Biomarkers endorses the EQUATOR Network initiative, which promotes the transparent and accurate reporting of health research. Authors are required to identify the relevant reporting checklist for their study type and ensure that it is completed and submitted along with their manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE
- Country or region
- Italy
- Language
- English
- ISSN
- 1849-4544
- Latest issue on the website
- Volume 15, Issue 1 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Circulating Biomarkers
How long does peer review take at Journal of Circulating Biomarkers?
Based on the dates recorded on 18 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 134 days (interquartile range 116–178 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Circulating Biomarkers?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: AMA; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Circulating Biomarkers based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (2), United States (1) and South Africa (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Circulating Biomarkers?
According to LetPub and DOAJ records, Journal of Circulating Biomarkers is indexed in Scopus and DOAJ.
Is Journal of Circulating Biomarkers open access, and what is the APC?
Journal of Circulating Biomarkers is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .